Actually an acquisition will be negative for the share price for at least 3 months.They will have to either make a scrip bid or have a rights issue.Both would tend to force the price down.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025